VANCOUVER, July 15, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results